We are live on ! Find out more
AGN

Allergan Inc
AGN

Delisted

AGN was delisted on the 16th of March, 2015.

17 hedge funds and large institutions have $16.8M invested in Allergan Inc in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

21% more funds holding

Funds holding: 1417 (+3)

15% more capital invested

Capital invested by funds: $14.6M → $16.8M (+$2.22M)

Holders
17
Holders Change
+3
Holders Change %
+21.43%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change

AGN Hedge Fund Activity: Q1 2017 in Review

17 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q1 2017, worth a combined $16.8M — up 15% from $14.6M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new AGN positions and 0 closed out — a net gain of 3 holders — while 6 added to existing stakes and 3 trimmed.

The largest buyer was Toth Financial Advisory, opening a new position worth an estimated $917K. The largest seller was Frontier Investment Management, cutting an estimated $2.08M.

  • 17 institutional investors held Allergan Inc (AGN) as of Q1 2017, up from 14 in Q4 2016.
  • Funds reported $16.8M of Allergan Inc stock for Q1 2017, up 15% quarter-over-quarter.
  • 3 funds opened new Allergan Inc positions in Q1 2017 and 0 closed out, a net change of +3 holders.
  • The largest Allergan Inc buyer in Q1 2017 was Toth Financial Advisory, an estimated $917K added.
  • The largest Allergan Inc seller in Q1 2017 was Frontier Investment Management, an estimated $2.08M sold.

Based on aggregated 13F filings for Q1 2017.